Autopsy and Case Reports
Autopsy and Case Reports
Article / Clinical Case Report

Oral carcinoma development after 23 years of renal transplantation

Isabel Schausltz Pereira Faustino; Diego Teztner Fernandes; Alan Santos-Silva; Pablo Agustin Vargas; Marcio Ajudarte Lopes

Downloads: 0
Views: 44


Renal transplant patients are treated with immunosuppressive drugs that decrease the effectiveness of the immune system, making them more prone to developing cancer. Skin and lip carcinomas are common malignancies encountered after transplantation, whereas oral carcinomas are rare. We report the case of a 51-year-old female Caucasian patient, with no history of smoking, who presented white lesions on the tongue and an ulcerated lesion on the lower lip beginning 4 months prior. Diagnosis of squamous cell carcinoma for both lesions was made following incisional biopsies. Interestingly, the patient reported a renal transplantation 23 years prior, and was maintained on a combination of cyclosporine, mycophenolate sodium and prednisone. The patient also presented a history of several basal and squamous cell carcinomas on sun-exposed areas of the skin. Both lesions were surgically excised. No sign of recurrence or new lesions in the oral cavity have been observed; however, new skin lesions are frequently diagnosed. This case report highlights that oral cancers may occur in transplant patients in the absence of classical risk factors. Thus, clinicians must be aware of the importance of thorough oral examination in transplant patients in routine follow-up.


Lip neoplasm, Tongue neoplasm, Mouth neoplasm, Kidney transplantation


Wolfe RA, Ashby VB, Milford EF, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-30. 10.1056/NEJM199912023412303.10580071

Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost utility of renal transplantation. Kidney Int. 1996;50(1):235-42. 10.1038/ki.1996.307.8807593

Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA. 2006;296(23):2823-31. 10.1001/jama.296.23.2823.17179459

Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am. 1993;7(2):431-45. 10.1016/S0889-8588(18)30250-8.8468275

Ho M. Risk factors and pathogenesis of posttransplant lymphoproliferative disorders. Transplant Proc. 1995;27(5, Suppl 1):38-40.7482816

Levy JA. A new human herpesvirus: KSHV or HHV8? Lancet. 1995;346(8978):786. 10.1016/S0140-6736(95)91611-3.7674737

Pendón-Ruiz de Mier V, Navarro Cabello MD, Martínez Vaquera S, et al. Incidence and long-term prognosis of cancer after kidney transplantation. Transplant Proc. 2015;47(9):2618-21. 10.1016/j.transproceed.2015.08.043.26680052

Penn I. Depressed immunity and the development of cancer. Cancer Detect Prev. 1994;18(4):241-52.7982234

Laprise C, Cahoon EK, Lynch CF, et al. Risk of lip cancer after solid organ transplantation in the United States. Am J Transplant. 2019;19(1):227-37. 10.1111/ajt.15052.30074684

Lee YW, Gisser SD. Squamous cell carcinoma of the tongue in a nine year renal transplant survivor: a case report with a discussion of the risk of development of epithelial carcinomas in renal transplant survivors. Cancer. 1978;41(1):1-6. 10.1002/1097-0142(197801)41:1<1::AID-CNCR2820410101>3.0.CO;2-1.342080

Meng S, Jiamei L. Management of tongue cancer in the patient who is systemically immunosuppressed: a preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(6):689-93. 10.1067/moe.2000.111411.11113812

Zhang L, Epstein JB, Poh CF, et al. Comparison of HPV infection, p53 mutation and allelic losses in post-transplant and non-posttransplant oral squamous cell carcinomas. J Oral Pathol Med. 2002;31(3):134-41. 10.1034/j.1600-0714.2002.310302.x.11903818

Malleshappa P, Aghariya M, Tampi C, Shah BV. Squamous cell carcinoma of tongue in a renal transplant recipient. Indian J Med Paediatr Oncol. 2009;30(4):136-7. 10.4103/0971-5851.65336.20838555

Prakash J, Prabhakar H, Kumar M, Aralapuram K. Carcinoma of the tongue in a renal transplant recipient: a rare post-transplant malignancy. Saudi J Kidney Dis Transpl. 2015;26(1):103-6. 10.4103/1319-2442.148753.25579725

Andrés A. Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hematol. 2005;56(1):71-85. 10.1016/j.critrevonc.2004.11.010.15978827

Villeneuve PJ, Schaubel DE, Fenton SS, Shepherd FA, Jiang Y, Mao Y. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant. 2007;7(4):941-8. 10.1111/j.1600-6143.2007.01736.x.17331115

Webster AC, Craig JC, Simpson JM, Jones MP, Chapman JR. Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15183 recipients. Am J Transplant. 2007;7(9):2140-51. 10.1111/j.1600-6143.2007.01908.x.17640312

van Leeuwen MT, Grulich AE, McDonald SP, et al. Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev. 2009;18(2):561-9. 10.1158/1055-9965.EPI-08-0919.19190169

Yarosh DB, Pena AV, Nay SL, Canning MT, Brown DA. Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J Invest Dermatol. 2005;125(5):1020-5. 10.1111/j.0022-202X.2005.23858.x.16297204

Canning MT, Nay S, Peña A, Yarosh DB. Calcineurin inhibitors reduce nuclear localization of transcription factor NFAT in UVirradiated keratinocytes and reduce DNA repair. J Mol Histol. 2006;37(5-7):285-91. 10.1007/s10735-006-9034-9.16927198

Demir T, Ozel L, Gökçe AM, et al. Cancer screening of renal transplant patients undergoing long-term immunosuppressive therapy. Transplant Proc. 2015;47(5):1413-7. 10.1016/j.transproceed.2015.04.073.26093731

Guba M, Graeb C, Jauch KW, Geissler EK. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation. 2004;77(12):1777-82. 10.1097/01.TP.0000120181.89206.54.15223891

Hibberd AD, Trevillian PR, Wlodarczyk JH, et al. Effect of immunosuppression for primary renal disease on the risk of cancer in subsequent renal transplantation: a population-based retrospective cohort study. Transplantation. 2013;95(1):122-7. 10.1097/TP.0b013e3182782f59.23238532

van Leeuwen MT, Webster AC, McCredie MRE, et al. Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ. 2010;340:c570. 10.1136/bmj.c570.20150194

López-Pintor RM, Hernández G, Arriba L, Andrés A. Lip cancer in renal transplant patients. Oral Oncol. 2011;47(1):68-71. 10.1016/j.oraloncology.2010.10.017.21112239

Unsworth JD, Baldwin A, Byrd L. Systemic lupus erythematosus, pregnancy and carcinoma of the tongue. BMJ Case Rep. 2013;31:2013. 10.1136/bcr-2013-008864.23729701

Song L, Wang Y, Zhang J, Song N, Xu X, Lu Y. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis. Arthritis Res Ther. 2018;20(1):270. 10.1186/s13075-018-1760-3.30522515

Wong G, Chapman JR. Cancers after renal transplantation. Transplant Rev (Orlando). 2008;22(2):141-9. 10.1016/j.trre.2007.12.004.18631867

Joshi K, Vivekanand J. Malignancies following kidney transplantation. JNRT. 2009;2(1):94-105.

van Zuuren EJ, Visscher JG, Bavinck JNB. Carcinoma of the lip in kidney transplant recipients. J Am Acad Dermatol. 1998;38(3):497-9. 10.1016/S0190-9622(98)70516-X.9520038

Jadotte YT, Schwartz RA. Solar cheilosis: an ominous precursor: part I. Diagnostic insights. J Am Acad Dermatol. 2012;66(2):173-86. 10.1016/j.jaad.2011.09.040.22243721

Nico MMS, Rivitti EA, Lourenco SV. Actinic cheilitis: histologic study of the entire vermilion and comparison with previous biopsy. J Cutan Pathol. 2007;34(4):309-14. 10.1111/j.1600-0560.2006.00606.x.17381801

Kumar M, Nanavati R, Modi TG, Dobariya C. Oral cancer: etiology and risk factors – a review. J Cancer Res Ther. 2016;12(2):458-63. 10.4103/0973-1482.186696.27461593

Gueiros LA, Coletta RD, Kowalski LP, Lopes MA. Clinicopathological features and proliferation markers in tongue squamous cell carcinomas. Int J Oral Maxillofac Surg. 2011;40(5):510-5. 10.1016/j.ijom.2010.12.008.21277167








Publication date:

5d8226830e8825954ebbebff autopsy Articles
Links & Downloads

Autops Case Rep

Share this page
Page Sections